JIANGXI BANK (01916) has been approved to issue capital supplement bonds and ordinary financial bonds.
Jiangxi Bank (01916) announced that it has recently received the "Administrative Licensing Approval Decision" (Yin Xu Zhun Yu Jue Zi [2026] No. 70) from the People's Bank of China, which permits the bank to issue capital supplement bonds in the national interbank market and overseas markets. The administrative license is valid until June 30, 2027. By the end of the validity period, the new balance of the bank's capital supplement bonds shall not exceed RMB 4 billion, and the total balance shall not exceed RMB 12 billion. The bank may choose the timing of the issuance in installments within the validity period.
JIANGXI BANK (01916) announced that it has recently received the "Administrative License Decision" from the People's Bank of China (Yin Xu Zhun Yu Jue Zi [2026] No. 70), which approves the bank to issue capital replenishment bonds in the national interbank market and overseas market. The administrative license is effective until June 30, 2027. By the end of the validity period, the new balance of the bank's capital replenishment bonds shall not exceed RMB 4 billion, and the total balance of capital replenishment bonds shall not exceed RMB 12 billion. The bank may choose the issuance timing in installments within the validity period.
The bank also received the "Administrative License Decision" (Yin Xu Zhun Yu Jue Zi [2026] No. 71), which approves the bank to issue ordinary financial bonds (including financial bonds with specific fundraising purposes, hereinafter the same) in the national interbank market and overseas market. The administrative license is also effective until June 30, 2027. By the end of the validity period, the new balance of ordinary financial bonds shall not exceed RMB 2 billion, and the total balance of ordinary financial bonds shall not exceed RMB 16 billion. The bank may choose the issuance timing in installments within the validity period.
The bank also recently received the "Reply from the Jiangxi Financial Regulatory Bureau on the Issuance of Capital Instruments by JIANGXI BANK" (Gan Jin Jian Fu [2026] No. 142), in which the Jiangxi Financial Regulatory Bureau has approved the bank to issue capital instruments not exceeding RMB 11 billion, comprising perpetual capital bonds and subordinated capital bonds. The bank may independently decide the timing, batch, and scale of issuance within the approved quota and complete the issuance within 24 months after approval.
Related Articles

JIANGSU EXPRESS (00177) has completed the issuance of 590 million yuan in super short-term financing bonds.

CSPC PHARMA (01093) received a $10 million milestone payment from AstraZeneca under the strategic research and development cooperation agreement.

SOCAM DEV (00983) issued a positive profit alert, anticipating a net profit attributable to shareholders of approximately HKD 28 million to HKD 33 million for the interim period, compared to a loss in the same period last year.
JIANGSU EXPRESS (00177) has completed the issuance of 590 million yuan in super short-term financing bonds.

CSPC PHARMA (01093) received a $10 million milestone payment from AstraZeneca under the strategic research and development cooperation agreement.

SOCAM DEV (00983) issued a positive profit alert, anticipating a net profit attributable to shareholders of approximately HKD 28 million to HKD 33 million for the interim period, compared to a loss in the same period last year.

RECOMMEND





